Drugs / OriV508
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07101705 | Sep 2025 → Aug 2028 expected | non-Hodgkin lymphoma, plasma cell myeloma | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OriV508 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07101705 ↗ |
| Route | Intravenous | “can be administered intravenously” NCT07101705 ↗ |